BIOA - NASDAQ

BioAge Labs, Inc.

BIOA·NASDAQ

$16.52

-0.12%

HealthcareBiotechnology

BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets based on insights into molecular changes that drive aging. Its product includes azelaprag, an orally available small molecule that is in phase 1 clinical trial for the treatment of obesity; and initiated phase 2 clinical trial of azelaprag in combination with tirzepatide for the treatment of obesity in older adults. It also develops BGE-100, an orally available small molecule brain-penetrant NLRP3 antagonist for the treatment of diseases driven by neuroinflammation. The company was incorporated in 2015 and is based in Richmond, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$621.97M

EPS-2.2400

P/E Ratio-7.37

Earnings Date08/05/2026

bioa

Operating Cash Flow

Last Annual Value

-81.63M

3-Year CAGR

-31%

5-Year CAGR

-18%

10-Year CAGR

-8%

Adjust for Inflation

BioAge Labs, Inc. Competitors Analysis of Operating Cash Flow

BIOA · NASDAQ

Company	Operating Cash Flow	CAGR 3Y	CAGR 5Y	CAGR 10Y
BioAge Labs, Inc. NASDAQ:BIOA	-81.63M	N/A	N/A	N/A
Atea Pharmaceuticals, Inc. NASDAQ:AVIR	-132.03M	N/A	N/A	N/A
Cabaletta Bio, Inc. NASDAQ:CABA	-131.08M	N/A	N/A	N/A
Pyxis Oncology, Inc. NASDAQ:PYXS	-63.50M	N/A	N/A	N/A
Vor Biopharma Inc. NASDAQ:VOR	-142.71M	N/A	N/A	N/A
Humacyte, Inc. NASDAQ:HUMA	-105.04M	N/A	N/A	N/A
Aclaris Therapeutics, Inc. NASDAQ:ACRS	-47.11M	N/A	N/A	N/A
Atlantic International Corp. NASDAQ:ATLN	-4.40M	N/A	N/A	N/A
Corbus Pharmaceuticals Holdings, Inc. NASDAQ:CRBP	-64.49M	N/A	N/A	N/A
Journey Medical Corporation NASDAQ:DERM	-12.44M	N/A	N/A	N/A
Health Catalyst, Inc. NASDAQ:HCAT	731.00K	N/A	N/A	N/A

BioAge Labs, Inc. Fair Value Envelope

BIOA · NASDAQ

Our analysis suggests that BIOA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $16.52, this represents a potential HIDDEN relative to our calculated worth for BioAge Labs, Inc..

HIDDEN

Intrinsic Value

Current Price: $16.52

Related Guides

Blog Categories

Continue your BIOA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.